Intranasal Insulin for COVID-19-related Smell Loss

NCT05461365 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Anosmia
Smell Loss
Paraosmia
Hyposmia
COVID-19

Interventions

DRUG: Insulin

Sponsor

Universidad Panamericana